| Ms Stephanie Katarina Hionidis, PA | |
|
334 Main St, Dickson City, PA 18519-1668 | |
| (570) 307-1767 | |
| Not Available |
| Full Name | Ms Stephanie Katarina Hionidis |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 334 Main St, Dickson City, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477169969 | NPI | - | NPPES |
| MA061857 | Other | PA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MA0619857 (Pennsylvania) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | MA0619857 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regional Hospital Of Scranton | Scranton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).
Many companies and their lobbyists now believe the overhaul is inevitable and are hoping to ease changes that will affect their businesses.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland, the first clinical site in Poland and the first center in the EU.
Allan Reiss, MD, and his colleagues have a pretty good idea why your husband or boyfriend can't put down the Halo 3. In a first-of-its-kind imaging study, the Stanford University School of Medicine researchers have shown that the part of the brain that generates rewarding feelings is more activated in men than women during video-game play.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Stephanie Katarina Hionidis, PA 1605 N Cedar Crest Blvd Ste 411, Allentown, PA 18104-2323 Ph: (484) 629-2282 | Ms Stephanie Katarina Hionidis, PA 334 Main St, Dickson City, PA 18519-1668 Ph: (570) 307-1767 |
News Archive
Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).
Many companies and their lobbyists now believe the overhaul is inevitable and are hoping to ease changes that will affect their businesses.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland, the first clinical site in Poland and the first center in the EU.
Allan Reiss, MD, and his colleagues have a pretty good idea why your husband or boyfriend can't put down the Halo 3. In a first-of-its-kind imaging study, the Stanford University School of Medicine researchers have shown that the part of the brain that generates rewarding feelings is more activated in men than women during video-game play.
› Verified 1 days ago